Nirsevimab immunization effectively decreases the risk for RSV-related LRTI hospitalizations in an infant's first year.
Meningitis incidence and mortality declined significantly in the Western Pacific Region from 1990 to 2023 following expanded vaccination initiatives.
Coadministration of the MenACYW-TT vaccine with routine pediatric immunizations is well tolerated among healthy infants and ...
Long-term data suggest that patients with pneumococcal meningitis originating from hematogenous spread experience the highest rates of 30-day mortality, though the overall burden of resistant disease ...
Adults with HIV aged 60 years and older are more likely to report favorable quality of life (QOL) following a switch in antiretroviral therapy (ART) than adults younger than 60 ye ...
The respiratory syncytial virus prefusion F protein-based vaccine does not increase the risk for severe myocarditis or pericarditis in adults.
Long-term fumarate therapy for multiple sclerosis, compared with anti-CD20 therapy, is linked to a reduced risk for infection.
Updated BNT162b2 KP.2 vaccination reduces COVID-19 hospitalizations and ED visits in immunocompetent adults regardless of risk status.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results